Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Differential Expression of SHP-1 Levels in Chronic Phase and Advanced Disease CML and in AML Patients

Jaspal S Kaeda, PhD, Christian Oberender, Daniel Neuman, Theo Kim, MD, Ken I Mills, PhD, Anna Serra, PhD, Philipp Hemmati, MD, Regina Schleede, Tim Overkamp, Frauke Ringel, PhD, Thomas Pretzsch, Seval Turkmen, MD, Michaela Schwarz, MD, Renate Arnold, MD, Bernd Dörken, MD, Philipp le Coutre, MD

Blood (2012) 120 (21): 1449.

https://doi.org/10.1182/blood.V120.21.1449.1449

Published: 2012

Journal Articles

Impact of Early Blast Clearance Following Induction Chemotherapy On the Outcome of Patients with Acute Myelod Leukemia Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Philipp le Coutre, MD, Gero Massenkeil, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2012) 120 (21): 1998.

https://doi.org/10.1182/blood.V120.21.1998.1998

Published: 2012

Journal Articles

Targeting Notch and Hedgehog Embryonic Signaling Pathways Has Potent Anti-Tumor Activity in Myeloma and Is Effective in Myeloma Bone Disease.

Rolf Schwarzer, Nicole Schünemann, David M Wong, Bjarne Bogen, Kurt Bommert, Bernd Dörken, MD, Rudolf Manz, Franziska Jundt, MD

Blood (2012) 120 (21): 2938.

https://doi.org/10.1182/blood.V120.21.2938.2938

Published: 2012

Journal Articles

Therapy-Senescent Lymphoma Cells Bear Potentially Detrimental Stem-Cell Characteristics.

Maja Milanovic, Jan Dörr, Dido Lenze, Michael Hummel, Bernd Dörken, MD, Clemens Schmitt, MD

Blood (2010) 116 (21): 2836.

https://doi.org/10.1182/blood.V116.21.2836.2836

Published: 2010

Journal Articles

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Unn-Merete Fagerli, MD, PhD, Thorsten Stühmer, PhD, Toril Holien, Randi Utne Holt, PhD, Ove Bruland, PhD, Manik Chatterjee, MD, John Shaughnessy, Jr, PhD, Stephan Mathas, MD, Anders Sundan, MD, Ralf C Bargou, MD, Bernd Dörken, MD, Magne Borset, MD, PhD, Martin Janz, MD

Blood (2010) 116 (21): 1915.

https://doi.org/10.1182/blood.V116.21.1915.1915

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation for Secondary or Therapy-Related Acute Myeloid Leukemia or Myelodysplastic Syndrome with Poor-Risk Cytogenetics.

Philipp G. Hemmati, MD, Theis Terwey, MD, Philipp D. le Coutre, MD, Gero Massenkeil, MD, Lam G Vuong, MD, PhD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2010) 116 (21): 3470.

https://doi.org/10.1182/blood.V116.21.3470.3470

Published: 2010

Journal Articles

Anti-CD20 Immunotherapy Augments the Chemotherapy-Induced Senescence Response In Human Lymphoma Cells

J. Henry M. Däbritz, Yong Yu, Mathias T. Rosenfeldt, MD, Bernd Dörken, MD, Clemens A. Schmitt, MD

Blood (2010) 116 (21): 1827.

https://doi.org/10.1182/blood.V116.21.1827.1827

Published: 2010

Journal Articles

High-Level Expression of Mastermind-Like 2 (MAML2) Contributes to Aberrant Activation of the NOTCH Signaling Pathway In Human Lymphomas

Karl Köchert, Stephan Kreher, Jon C Aster, MD, PhD, Motoo Kitagawa, Korinna Jöhrens, Ioannis Anagnostopoulos, Franziska Jundt, MD, PD, Harald Stein, MD, Martin Janz, MD, Bernd Dörken, MD, Stephan Mathas, MD

Blood (2010) 116 (21): 2685.

https://doi.org/10.1182/blood.V116.21.2685.2685

Published: 2010

Journal Articles

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Blood (2009) 114 (22): 100.

https://doi.org/10.1182/blood.V114.22.100.100

Published: 2009

Journal Articles

Pre-Transplant Risk-Assessment for Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplants.

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Philipp le Coutre, MD, Gero Massenkeil, MD, Lam G Vuong, PhD, Christian Jakob, MD, Arturo Vega, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2009) 114 (22): 2302.

https://doi.org/10.1182/blood.V114.22.2302.2302

Published: 2009

Journal Articles

Secondary Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation

Stefan Neuburger, MD, Philipp Hemmati, MD, Theis Terwey, MD, Gero Massenkeil, MD, Bernd Dörken, MD, Renate Arnold, MD, PhD

Blood (2008) 112 (11): 4297.

https://doi.org/10.1182/blood.V112.11.4297.4297

Published: 2008

Journal Articles

Cellular Senescence Contributes to the Outcome of Lymphoma Chemotherapy by Cell-Autonomous and Paracrine Immune Mechanisms

Jan Dörr, Yong Yu, Bernd Dörken, MD, Clemens A. Schmitt, MD

Blood (2008) 112 (11): 3617.

https://doi.org/10.1182/blood.V112.11.3617.3617

Published: 2008

Journal Articles

Decitabine: Where Is the Target?.

Ingo Tamm, MD, Nicole Sattler, PhD, Mandy Wagner, PhD, Michael Lübbert, MD, Philipp leCoutre, MD, Bernd Dörken, MD, Karin Schmelz, PhD

Blood (2005) 106 (11): 495.

https://doi.org/10.1182/blood.V106.11.495.495

Published: 2005

Journal Articles

Structural and Complex Chromosomal Aberrations Frequently Develop in Skin Fibroblasts after Allogeneic Stem Cell Transplantation.

Gero Massenkeil, MD, Petra Zschieschang, MD, Julia Pross, Ingo Tamm, MD, Stephan Neuburger, MD, Christoph Lutz, MD, Oliver Rosen, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2005) 106 (11): 1118.

https://doi.org/10.1182/blood.V106.11.1118.1118

Published: 2005

Journal Articles

Human BDCA-1 Positive Blood Dendritic Cells in Immunosuppressed Patients: Phenotype, Function and Maturation.

Kathrin Sebelin, Dipl. Biochem., Antje Meier, Carola Beier, Bernd Dörken, MD, Antonio Pezzutto, MD, Marion Subklewe, MD

Blood (2005) 106 (11): 2231.

https://doi.org/10.1182/blood.V106.11.2231.2231

Published: 2005

Journal Articles

Arsenic Trioxide Induces Regulated, Death Receptor- and Caspase-Independent Cell Death through the Mitochondrial Death Pathway.

Christian Scholz, MD, Antje Richter, Mario Lehmann, Klaus Schulze-Osthoff, MD, Bernd Dörken, MD, Peter T. Daniel, MD

Blood (2005) 106 (11): 4421.

https://doi.org/10.1182/blood.V106.11.4421.4421

Published: 2005

Journal Articles

Simultaneous Cytokine Analysis by Cytometric Bead Array (CBA) Allows More Sensitive Detection of Leukemia-Reactive T Cells in Patients with Chronic Myeloid Leukemia.

Jörg Westermann, MD, Antje van Lessen, Claudia Schlimper, MD, Gökben Baskaynak, MD, Philipp Le Coutre, MD, Bernd Dörken, MD, Antonio Pezzutto, MD

Blood (2005) 106 (11): 2879.

https://doi.org/10.1182/blood.V106.11.2879.2879

Published: 2005

Journal Articles

p38 MAPK Mediates Inhibition of Activation Induced Cell Death in T Lymphocytes Via Upregulation of Bcl-x L and FLIP short upon Ligation of CD137/4-1BB or CD28.

Christian Scholz, MD, Lilian Stärck, Mario Lehmann, Bernd Dörken, MD, Peter T. Daniel, MD

Blood (2005) 106 (11): 3320.

https://doi.org/10.1182/blood.V106.11.3320.3320

Published: 2005

Journal Articles

Non-Genotoxic Targeting of p53-Dependent and p53-Independent Signaling Pathways Efficiently Kills Hodgkin/Reed-Sternberg Cells.

Martin Janz, MD, Thorsten Stühmer, PhD, Bernd Dörken, MD, Ralf Bargou, MD

Blood (2005) 106 (11): 964.

https://doi.org/10.1182/blood.V106.11.964.964

Published: 2005

Journal Articles

Cologne High-Dose Sequential Chemotherapy in Relapsed and Refractory Hodgkin Lymphoma - Results of a Large Multicenter Study of the German Hodgkin Lymphoma Study Group (GHSG).

Andreas Josting, MD, Christian Rudolph, MD, Markus Mapara, MD, Jan-Peter Glossmann, MD, Markus Sieber, MD, Hartmut H. Kirchner, MD, Bernd Dörken, MD, Dieter K. Hossfeld, MD, Jens Kisro, MD, Bernd Metzner, MD, Wolfgang E. Berdel, MD, Volker Diehl, MD, Andreas Engert, MD

Blood (2004) 104 (11): 309.

https://doi.org/10.1182/blood.V104.11.309.309

Published: 2004

NARROW

Differential Expression of SHP-1 Levels in Chronic Phase and Advanced Disease CML and in AML Patients

Impact of Early Blast Clearance Following Induction Chemotherapy On the Outcome of Patients with Acute Myelod Leukemia Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Targeting Notch and Hedgehog Embryonic Signaling Pathways Has Potent Anti-Tumor Activity in Myeloma and Is Effective in Myeloma Bone Disease.

Therapy-Senescent Lymphoma Cells Bear Potentially Detrimental Stem-Cell Characteristics.

Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells

Allogeneic Stem Cell Transplantation for Secondary or Therapy-Related Acute Myeloid Leukemia or Myelodysplastic Syndrome with Poor-Risk Cytogenetics.

Anti-CD20 Immunotherapy Augments the Chemotherapy-Induced Senescence Response In Human Lymphoma Cells

High-Level Expression of Mastermind-Like 2 (MAML2) Contributes to Aberrant Activation of the NOTCH Signaling Pathway In Human Lymphomas

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Pre-Transplant Risk-Assessment for Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplants.

Secondary Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation

Cellular Senescence Contributes to the Outcome of Lymphoma Chemotherapy by Cell-Autonomous and Paracrine Immune Mechanisms

Decitabine: Where Is the Target?.

Structural and Complex Chromosomal Aberrations Frequently Develop in Skin Fibroblasts after Allogeneic Stem Cell Transplantation.

Human BDCA-1 Positive Blood Dendritic Cells in Immunosuppressed Patients: Phenotype, Function and Maturation.

Arsenic Trioxide Induces Regulated, Death Receptor- and Caspase-Independent Cell Death through the Mitochondrial Death Pathway.

Simultaneous Cytokine Analysis by Cytometric Bead Array (CBA) Allows More Sensitive Detection of Leukemia-Reactive T Cells in Patients with Chronic Myeloid Leukemia.

p38 MAPK Mediates Inhibition of Activation Induced Cell Death in T Lymphocytes Via Upregulation of Bcl-x L and FLIP short upon Ligation of CD137/4-1BB or CD28.

Non-Genotoxic Targeting of p53-Dependent and p53-Independent Signaling Pathways Efficiently Kills Hodgkin/Reed-Sternberg Cells.

Cologne High-Dose Sequential Chemotherapy in Relapsed and Refractory Hodgkin Lymphoma - Results of a Large Multicenter Study of the German Hodgkin Lymphoma Study Group (GHSG).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only